Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab for osseointegrated femoral amputation prostheses
2012-003574-66Phase 4Terminated
- Sponsor
- Aarhus University Hospital
- Start
- Jan 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4 trial of denosumab in Leg amputation, osteoporosis and musculoskeletal condition (MSK), sponsored by Aarhus University Hospital. Primary endpoint: Bone mineral density (BMD) changes. Started Jan 2013; status: terminated.
02
Drugs
denosumab
03
Conditions
Leg amputationosteoporosismusculoskeletal condition (MSK)
Beyond the preview
Go deeper on 2012-003574-66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003574-66.